The American Journal of Therapeutics, which is not political, did a Meta Analysis review of ivermectin. Here is the conclusion and I posted the link to the review below.
Conclusions:
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
https://journals.lww.com/americanthe...uKbEUFzDlhzWk4
